全球宫颈癌发病与死亡的近期负担、预测因素及时间趋势
该研究利用全球癌症观察站2020年185个国家数据,分析宫颈癌发病与死亡及其与预测因素的关联,并用53个国家癌症登记数据至2018年做趋势分析。全球差异大,东非发病与死亡ASR最高(40.1和28.6);发病与死亡同HPV、HIV感染正相关,与筛查覆盖率负相关。多数国家发病与死亡下降,但部分发达国家年轻女性发病上升。
要点
- 全球宫颈癌负担差异显著,东非发病与死亡ASR最高(40.1和28.6)。
- 发病与死亡同HPV、HIV感染正相关,与宫颈癌筛查覆盖率负相关。
- 部分发达国家50岁以下女性发病上升,需加强有效筛查。
核心结论
- 多数有癌症登记的国家宫颈癌发病与死亡下降,但一些发达国家年轻女性发病上升,需进一步实施有效筛查。
研究设计与样本
- 基于全球癌症观察站2020年185个国家数据,线性回归分析发病与死亡同预测因素的关联。
- 利用癌症登记数据至2018年、最多53个国家,采用joinpoint回归分析年龄标化率(ASR)和平均年度百分比变化(AAPC)趋势。
主要发现
- 全球宫颈癌发病与死亡差异大,东非发病与死亡ASR最高(40.1和28.6)。
- 发病与死亡同人乳头瘤病毒(HPV)、人类免疫缺陷病毒(HIV)感染正相关,与宫颈癌筛查覆盖率负相关。
- 最近5年,22个国家发病下降(AAPC,-11.2至-0.5),27个国家死亡下降(-21.5至-0.3)。
- 13个国家发病上升(AAPC,1.7至6.5),5个国家死亡上升(0.3至1.8)。
- 与50岁以上女性相比,9个国家50岁以下女性发病额外上升(AAPC范围0.2至3.8)。
临床怎么用
- 应重视HPV和HIV感染者的宫颈癌防控,并提高筛查覆盖率以降低发病与死亡。
- 对部分发达国家年轻女性发病上升趋势,需进一步落实有效筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: This study investigated the global incidence and mortality of cervical cancer, its predictors, the temporal trend by country and age. METHODS: Data from Global Cancer Observatory 2020 for 185 countries was used to estimate current cervical cancer incidence and mortality and their associations with predictors by linear regression analysis. Estimated age-standardized rates (ASR) and average annual percentage changes (AAPC) from cancer registries for up to 53 countries through 2018 were used for trend analysis by joinpoint regression. RESULTS: Wide variations in cervical cancer were observed globally with the highest rates of incidence and mortality in East Africa (ASR, 40.1 and 28.6). The incidence and mortality of cervical cancer were positively associated with human papillomavirus, human immunodeficiency virus infection and negatively associated with cervical cancer screening coverage. In the most recent 5 years, reduction of incidence and mortality was found from 22 (AAPC, -11.2 to -0.5) and 27 countries (-21.5 to -0.3). Increase of incidence and mortality was found from 13 (1.7 to 6.5) and 5 (0.3 to 1.8) countries. Comparing to women aged above 50 years, increasing incidence were additionally found among women under age 50 years from 9 countries (ranging from 0.2 in Denmark to 3.8 in Sweden). CONCLUSIONS: While most countries with cancer registry have shown reduction in cervical cancer incidence and mortality, the increasing incidence among younger women from some developed countries warrants further implementation of effective cancer screening.
引用
- He WQ, Li C. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecol Oncol. 2021. PMID: 34688503. doi:10.1016/j.ygyno.2021.10.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。